Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA322076 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Estrogen Receptor Alpha Signaling in Cervical Cancer Associated Fibroblasts
| PRJNA273453 | ENA
Project description:Coativator Function Defines the Active Estrogen Receptor Alpha Cistrome
| PRJNA121689 | ENA
Project description:GPR30-mediated estrogen signaling in Estrogen Receptor alpha and beta negative SKBR3 breast cancer cells
| PRJNA106185 | ENA
Project description:<p>BRCA1 mutations are a hallmark of hereditary ovarian cancer, strongly linked to deficiencies in homologous recombination (HR) DNA repair and impaired DNA replication fork protection. However, its roles in cancer progression beyond maintaining genomic integrity remain poorly understood. Through metabolomics approaches, we found BRCA1-deficiency strikingly increased choline metabolism. Loss of BRCA1 promotes choline uptake through upregulating choline transporter-like protein 4 (CTL4). BRCA1 directly binds and recruits EZH2-mediated H3K27Me3 deposition to CTL4 promoter. CTL4 was therefore overexpressed in ovarian cancer tissues with BRCA1 mutations. Furthermore, BRCA1-deficiency significantly promotes ovarian cancer invasion, while inhibition of CTL4 reverses the high metastatic potential of BRCA1-deficient ovarian cancer cells, suggesting the functionality and specificity of CTL4 as a therapeutic target. Additionally, we discovered that phosphocholine, the choline metabolite increased by CTL4 overexpression, interacted with and stabilized the epithelial-to-mesenchymal transition inducer FAM3C in BRCA1-deficient ovarian cancer cells. Importantly, we identified a potent CTL4 inhibitor, DT-13, which significantly reduces choline metabolism and effectively suppresses metastasis in BRCA1-deficient ovarian cancers. Therefore, our study uncovers a mechanism underlying metastasis in BRCA1-deficient cancers and identifies CTL4 as a therapeutic target for metastatic ovarian cancer patients with BRCA1 mutations.</p>
2026-05-15 | MTBLS12245 | MetaboLights
Project description:Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.
| PRJNA128765 | ENA
Project description:Cross-talk between Estrogen Receptor-related Receptor alpha (ERRalpha) and Estrogen Receptor (ERalpha) pathways.
| PRJNA106665 | ENA
Project description:Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing
| PRJNA240965 | ENA
Project description:Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
| PRJNA362462 | ENA
Project description:Inhibition of CDK8 Mediator Kinase Suppresses Estrogen Receptor Signaling and Growth of Estrogen Receptor Positive Breast Cancer
| PRJNA360278 | ENA
Project description:Genomics of signalling crosstalk of estrogen receptor alpha in breast cancer cells
| PRJNA108025 | ENA